Targeted lung cancer drug shows promise in phase I/II clinical trial
Experimental drug to treat liver cancer shows evidence of activity with manageable side effects
27 October 2022Large stroke trial finds intensive blood pressure lowering after clot removal worsens recovery
28 October 2022Targeted lung cancer drug shows promise in phase I/II clinical trial
Early trials of the targeted drug repotrectinib suggest that it could help treat patients with a certain type of non-small cell lung cancer (NSCLC).
